Xinguo Jiang Selected Research

Angiopep-2

9/2017	On-Demand Drug Release from Dual-Targeting Small Nanoparticles Triggered by High-Intensity Focused Ultrasound Enhanced Glioblastoma-Targeting Therapy.
12/2014	Fluorescent carbonaceous nanodots for noninvasive glioma imaging after angiopep-2 decoration.
8/2014	Angiopep-2 and activatable cell-penetrating peptide dual-functionalized nanoparticles for systemic glioma-targeting delivery.
4/2012	The targeted delivery of anticancer drugs to brain glioma by PEGylated oxidized multi-walled carbon nanotubes modified with angiopep-2.
1/2012	Co-delivery of pEGFP-hTRAIL and paclitaxel to brain glioma mediated by an angiopep-conjugated liposome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xinguo Jiang Research Topics

Disease

59	Neoplasms (Cancer) 04/2021 - 03/2006
34	Glioma (Gliomas) 09/2016 - 01/2007
13	Glioblastoma (Glioblastoma Multiforme) 01/2018 - 08/2011
7	Inflammation (Inflammations) 01/2020 - 01/2006
7	Alzheimer Disease (Alzheimer's Disease) 10/2018 - 02/2012
7	Breast Neoplasms (Breast Cancer) 01/2015 - 01/2007
5	Pulmonary Arterial Hypertension 10/2019 - 08/2013
5	Hypoxia (Hypoxemia) 10/2019 - 11/2011
4	Lymphedema (Milroy Disease) 10/2020 - 10/2017
4	Brain Neoplasms (Brain Tumor) 09/2017 - 04/2010
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2015 - 07/2011
4	Central Nervous System Diseases (CNS Diseases) 01/2014 - 11/2008
3	Neoplasm Metastasis (Metastasis) 01/2020 - 12/2013
3	Amyloid Plaque 05/2019 - 01/2017
3	Pancreatic Neoplasms (Pancreatic Cancer) 12/2018 - 10/2016
3	Hemolysis 10/2018 - 01/2012
3	Pulmonary Hypertension 12/2015 - 08/2013
3	Ischemia 01/2014 - 11/2011
3	Cardiotoxicity 04/2012 - 07/2011
2	Vascular System Injuries 01/2021 - 01/2016
2	Memory Disorders (Memory Loss) 05/2019 - 07/2013
2	Necrosis 12/2017 - 01/2012
2	Vascular Remodeling 12/2015 - 05/2014
2	Human Influenza (Influenza) 11/2015 - 01/2006
2	Hypertrophy 06/2015 - 08/2013

Drug/Important Bio-Agent (IBA)

30	Pharmaceutical PreparationsIBA 12/2017 - 01/2007
29	Peptides (Polypeptides)IBA 05/2019 - 10/2008
20	Paclitaxel (Taxol)FDA LinkGeneric 01/2018 - 01/2011
15	LigandsIBA 12/2015 - 11/2008
12	Proteins (Proteins, Gene)FDA Link 10/2020 - 09/2010
10	Therapeutic UsesIBA 10/2016 - 10/2008
9	Docetaxel (Taxotere)FDA Link 12/2015 - 01/2012
7	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2017 - 12/2010
6	Lapatinib (GW572016)FDA Link 06/2016 - 11/2012
6	monomethoxypolyethyleneglycol- polylactide block copolymerIBA 12/2015 - 01/2013
6	Interleukin-13IBA 05/2014 - 01/2013
5	FibrinIBA 04/2021 - 01/2014
5	Leukotriene B4IBA 10/2018 - 08/2013
5	Angiopep-2IBA 09/2017 - 01/2012
5	AGRO 100IBA 03/2017 - 11/2011
5	Liposomes (Liposome)IBA 12/2015 - 07/2011
4	Antineoplastic Agents (Antineoplastics)IBA 01/2015 - 12/2010
4	polyethylene glycol-poly(lactide-co-glycolide)IBA 05/2014 - 08/2011
3	Semaxinib (SU5416)IBA 01/2021 - 10/2019
3	LeukotrienesIBA 01/2020 - 05/2014
3	Amyloid (Amyloid Fibrils)IBA 05/2019 - 01/2017
3	Messenger RNA (mRNA)IBA 05/2019 - 01/2017
3	Small Interfering RNA (siRNA)IBA 05/2019 - 01/2017
3	cyclopamineIBA 12/2018 - 10/2016
3	NucleolinIBA 03/2017 - 11/2011
3	Neuropilin-1IBA 09/2016 - 05/2014
3	Thromboplastin (Tissue Factor)IBA 04/2016 - 10/2012
3	Carbon Nanotubes (Carbon Nanotube)IBA 02/2016 - 04/2012
3	Cell-Penetrating PeptidesIBA 01/2015 - 08/2014
3	SolutionsIBA 07/2013 - 01/2007
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2012 - 07/2011
2	MonocrotalineIBA 10/2019 - 08/2013
2	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 10/2019 - 06/2015
2	Ketoprofen (Orudis)FDA LinkGeneric 10/2018 - 10/2017
2	poly(2-(dimethylamino)ethyl methacrylate)IBA 10/2018 - 01/2017
2	EnzymesIBA 10/2018 - 01/2017
2	Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA 10/2017 - 05/2014
2	Atrial Natriuretic Factor (ANF)IBA 09/2017 - 01/2015
2	poly(gamma-glutamylglutamine)paclitaxelIBA 03/2017 - 01/2011
2	Fibronectins (Fibronectin)IBA 10/2016 - 04/2014
2	ErbB Receptors (EGF Receptor)IBA 06/2016 - 09/2013
2	Epidermal Growth Factor (EGF)IBA 06/2016 - 01/2015
2	Factor VII (Proconvertin)IBA 04/2016 - 04/2014
2	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 02/2016 - 01/2014
2	cysteinyl-arginyl-glutamyl-lysyl-alanylIBA 02/2016 - 07/2015
2	poly(lactide) (polylactic acid)IBA 01/2016 - 01/2014
2	Nanoparticle Drug Delivery SystemIBA 01/2016 - 07/2015
2	Cysteine (L-Cysteine)FDA Link 01/2016 - 01/2014
2	Complement System Proteins (Complement)IBA 12/2015 - 11/2011
2	Lipid NanoparticlesIBA 12/2015 - 01/2014
2	AlbuminsIBA 12/2015 - 01/2007
2	AntigensIBA 11/2015 - 05/2014
2	VaccinesIBA 11/2015 - 05/2014
2	Poly(amidoamine)IBA 07/2015 - 04/2010
2	Drug CarriersIBA 07/2015 - 04/2012
2	PAMAM StarburstIBA 07/2015 - 04/2010
2	AcetylcholinesteraseIBA 06/2015 - 02/2012
2	LipidsIBA 05/2014 - 07/2013
2	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2014 - 02/2012
2	CytokinesIBA 01/2014 - 01/2012
2	Coloring Agents (Dyes)IBA 12/2013 - 12/2010
2	Lipoproteins (Lipoprotein)IBA 09/2013 - 11/2012
2	tLyP-1 peptideIBA 07/2013 - 01/2013
2	NeuropilinsIBA 07/2013 - 01/2013
2	Transferrin (beta 2 Transferrin)IBA 06/2013 - 06/2011
2	Biological ProductsIBA 04/2012 - 11/2008
2	Fluorescent Dyes (Fluorescent Probes)IBA 02/2012 - 01/2007

Therapy/Procedure

32	Therapeutics 10/2018 - 07/2011
13	Drug Therapy (Chemotherapy) 01/2018 - 01/2007
6	Intranasal Administration 12/2015 - 01/2006
5	Photothermal Therapy 09/2017 - 04/2013
4	Immunotherapy 01/2020 - 01/2014
3	Lung Transplantation 01/2014 - 06/2011
2	Intravenous Administration 05/2019 - 05/2014
2	Lasers (Laser) 12/2017 - 01/2015